Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-02 Option Award | 2026-04-06 5:56 pm | N/A 2036-04-02 | 20/20 Biolabs Inc. | AIDX | Bergman Alan B. Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-04-02 Option Award | 2026-04-06 5:56 pm | 2026-04-02 2036-04-02 | 20/20 Biolabs Inc. | AIDX | Zhou Jiming Chief Operating Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-04 5:48 pm | N/A 2036-03-03 | 20/20 Biolabs Inc. | AIDX | Cohen Jonathan M Chief Executive Officer 10% Owner | 352,936 | $0 | 352,936 (Direct) | View |
| 2026-02-19 Conversion | 2026-02-23 7:09 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | Rollins John Woodson Director | 19,164 | $0 | 30,275 (Direct) | View |
| 2026-02-19 Conversion | 2026-02-23 6:13 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | Ross Michael A. Director | 31 | $0 | 31 (Direct) | View |
| 2026-02-19 Conversion | 2026-02-23 6:13 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | Compton John G. Director | 7,669 | $0 | 14,335 (Direct) | View |
| 2026-02-19 Conversion | 2026-02-23 6:13 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | COHEN RICHARD M Director | 7,700 | $0 | 7,700 (Direct) | View |
Ownership | 2026-02-23 6:12 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | Rollins John Woodson Director | 0 | $0 | 290,850 (Direct) | View |
Ownership | 2026-02-19 5:52 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | Cohen Jonathan M Chief Executive Officer 10% Owner | 0 | $0 | 1,879,400 (Direct) | View |
Ownership | 2026-02-17 6:29 pm | N/A 2033-01-01 | 20/20 Biolabs Inc. | AIDX | Lebowitz Michael Saul Chief Scientific Officer | 0 | $0 | 100,000 (Direct) | View |
Ownership | 2026-02-17 6:29 pm | N/A 2033-01-01 | 20/20 Biolabs Inc. | AIDX | Baker Ron Chief Business Officer | 0 | $0 | 75,000 (Direct) | View |
Ownership | 2026-02-17 6:28 pm | N/A 2034-07-01 | 20/20 Biolabs Inc. | AIDX | Reddy Prasanth Director | 0 | $0 | 30,000 (Direct) | View |
Ownership | 2026-02-17 6:28 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | Compton John G. Director | 0 | $0 | 274,910 (Direct) | View |
Ownership | 2026-02-17 6:28 pm | N/A 2033-01-01 | 20/20 Biolabs Inc. | AIDX | Zhou Jiming Chief Operating Officer | 0 | $0 | 522,000 (Direct) | View |
Ownership | 2026-02-17 6:27 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | COHEN RICHARD M Director | 0 | $0 | 268,275 (Direct) | View |
Ownership | 2026-02-17 6:27 pm | N/A N/A | 20/20 Biolabs Inc. | AIDX | Ross Michael A. Director | 0 | $0 | 260,606 (Direct) | View |